Globus Medical (GMED) Return on Invested Capital (2020 - 2025)

Globus Medical (GMED) posted Return on Invested Capital of 0.01% for Q3 2025, up 110.15% on a QoQ basis from 0.0% in Q2 2025, and little changed year-over-year from 0.01% in Q3 2024.

Globus Medical (GMED) Return on Invested Capital (2020 - 2025) Analysis & Trends

Globus Medical's Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.01% for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 0.01%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 0.01%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 0.01%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 0.00%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 0.00%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Globus Medical 10.21 Bn 9.58 Bn 525.79 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 0.01%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2021 0.05%
Dec 31, 2020 0.03%
Sep 30, 2020 0.03%
Jun 30, 2020 0.05%